Edition:
United Kingdom

Meridian Bioscience Inc (VIVO.OQ)

VIVO.OQ on NASDAQ Stock Exchange Global Select Market

18.19USD
13 Dec 2018
Change (% chg)

-- (--)
Prev Close
$18.19
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
81,649
52-wk High
$19.82
52-wk Low
$13.55

Chart for

About

Meridian Bioscience, Inc. is a life science company engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, viral, respiratory and parasitic infectious diseases, and elevated blood lead levels, and the manufacture and distribution of bulk antigens, antibodies, polymerase chain... (more)

Overall

Beta: 0.89
Market Cap(Mil.): $620.38
Shares Outstanding(Mil.): 42.20
Dividend: 0.12
Yield (%): 3.40

Financials

  VIVO.OQ Industry Sector
P/E (TTM): 29.32 32.18 34.39
EPS (TTM): 0.50 -- --
ROI: 9.27 13.76 14.96
ROE: 12.68 16.50 16.52

FDA approves Meridian Bioscience's test for herpes in newborns

The U.S. Food and Drug Administration approved on Friday the first test - a diagnostic from Meridian Bioscience Inc - to help detect a type of herpes virus in newborns.

30 Nov 2018

UPDATE 1-FDA approves Meridian Bioscience's test for herpes in newborns

Nov 30 The U.S. Food and Drug Administration approved on Friday the first test - a diagnostic from Meridian Bioscience Inc - to help detect a type of herpes virus in newborns.

30 Nov 2018

FDA approves Meridian Bioscience's diagnostic for herpes in newborns

Nov 30 The U.S. Food and Drug Administration approved on Friday a diagnostic test from Meridian Bioscience Inc as the first tool to help detect a type of herpes virus in newborns.

30 Nov 2018

Earnings vs. Estimates